Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific tổng số phê duyệt FDA PMA & Supplements toàn ngành tại Hoa Kỳ (U.S. Industry Total)
U.S. FDA openFDA Premarket Approval (PMA) API
Latest, FY2025
2,222
Period ended Dec 31, 2025
Change on a year earlier
-0.4%
2,230 in FY2024
History
10 years
Since FY2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Thermo Fisher Scientific Tổng số phê duyệt FDA PMA & Supplements toàn ngành tại Hoa Kỳ (U.S. Industry Total), annual FY2016–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda_pma_industry
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.